Researchers have identified a subpopulation of T cells as key cytokine producers in addition to proposing a novel mechanism of immunosuppression following superantigen exposure.
Browsing: Bacterial > MRSA
Researchers discover the susceptibility rates of Staphylococcus aureus to antibiotics increases over time.
A novel, bioinspired antimicrobial treatment, consisting of iodo-thiocyanate complexes, has demonstrated promising results as a bactericidal compound, according to new research.
Components from bacteria-infecting viruses could allow scientists to create hybrid human antibodies that can target carbohydrate molecules found on bacterial cell surfaces.
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
In this original research article, the authors determine the structural contributions of a compound set containing inhibitors of bacterial enzyme FabI.
Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery (CO-ADD) discusses his work towards uncovering compounds with antibiotic potential and shares his thoughts on the best strategies to tackle antibiotic resistance moving forwards.
The WHO has published a report this week listing 12 families of antibiotic-resistant bacteria that are thought to pose the greatest public health risk and should be the focus for new treatments.
In this study the authors delve into fighting antibiotic resistance, aiming to synthesize and evaluate the antimicrobial activity of a new series of quinazolinone azolyl ethanols .
Researchers have discovered that a component of the Staphylococcus aureus cell wall appears to be responsible for elevated virulence in community-associated MRSA infections. This mechanism could present a target for novel anti-infective strategies.